Abstract
Serial ultrasonic measurements of 82 uveal melanomas treated with brachytherapy plaques (cobalt-60 and iodine-125) and followed up for up to 141 months revealed that no two patients had identical patterns of change. The mean absolute change in tumour height after treatment was 1.8 mm at six months, 5.6 mm at 48 months for large tumours, and 0.9 and 1.9 mm for medium sized tumours. Eighty of the 82 patients fell into one of three patterns of response: 57 patients had a decrease in height after treatment (type D), 13 patients had the same height after treatment (type S), and 10 patients had a progressive increase in height (type I). Life table comparison showed no correlation between survival and location of tumour, sex of patient, size of tumour when treated, or laterality. There was a slight correlation between age and survival. Patients older than 60 died more frequently from metastatic melanoma than those under 60 (p = 0.06). Life table analysis showed a significant correlation between tumour regression type and survival. At 48 months the best cumulative probability of survival was in patients with type D (88% alive) compared with those of type I (34% alive, p = 0.0004).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Augsburger J. J., Gamel J. W., Shields J. A., Markoe A. M., Brady L. W. Post-irradiation regression of choroidal melanomas as a risk factor for death from metastatic disease. Ophthalmology. 1987 Sep;94(9):1173–1177. doi: 10.1016/s0161-6420(87)33310-x. [DOI] [PubMed] [Google Scholar]
- Augsburger J. J., McNeary B. T., von Below H., Gamel J. W., Shields J. A., Brady L. W., Markoe A. M., Day J. L. Regression of posterior uveal malignant melanomas after cobalt plaque radiotherapy. Graefes Arch Clin Exp Ophthalmol. 1986;224(5):397–400. doi: 10.1007/BF02173352. [DOI] [PubMed] [Google Scholar]
- Bedford M. A. The use and abuse of cobalt plaques in the treatment of choroidal malignant melanomata. Trans Ophthalmol Soc U K. 1973;93(0):139–143. [PubMed] [Google Scholar]
- Coleman D. J., Lizzi F. L., Silverman R. H., Ellsworth R. M., Haik B. G., Abramson D. H., Smith M. E., Rondeau M. J. Regression of uveal malignant melanomas following cobalt-60 plaque. Correlates between acoustic spectrum analysis and tumor regression. Retina. 1985 Spring-Summer;5(2):73–78. doi: 10.1097/00006982-198500520-00002. [DOI] [PubMed] [Google Scholar]
- Cruess A. F., Augsburger J. J., Shields J. A., Brady L. W., Markoe A. M., Day J. L. Regression of posterior uveal melanomas following cobalt-60 plaque radiotherapy. Ophthalmology. 1984 Dec;91(12):1716–1719. doi: 10.1016/s0161-6420(84)34087-8. [DOI] [PubMed] [Google Scholar]
- Long R. S., Galin M. A., Rotman M. Conservative treatment of intraocular melanomas. Trans Am Acad Ophthalmol Otolaryngol. 1971 Jan-Feb;75(1):84–93. [PubMed] [Google Scholar]
- Shields J. A., Augsburger J. J., Brady L. W., Day J. L. Cobalt plaque therapy of posterior uveal melanomas. Ophthalmology. 1982 Oct;89(10):1201–1207. doi: 10.1016/s0161-6420(82)34658-8. [DOI] [PubMed] [Google Scholar]
- Stallard H. B. Radiotherapy for malignant melanoma of the choroid. Br J Ophthalmol. 1966 Mar;50(3):147–155. doi: 10.1136/bjo.50.3.147. [DOI] [PMC free article] [PubMed] [Google Scholar]